-- 瑞銀證券週一在一份報告中指出，孩之寶（Hasbro，股票代碼：HAS）第一季的業績將主要取決於旗下威世智（Wizards of the Coast）部門的強勁需求，以及該公司如何將樹脂和運費上漲的影響納入損益表。 瑞銀表示，威世智的需求強勁主要得益於《忍者龜》（Teenage Mutant Ninja Turtles）和《史崔克斯海文的秘密》（Secrets of Strixhaven）在第一季強勁的預售表現。 瑞銀指出，鑑於樹脂價格上漲以及運費和分銷成本的增加，預計孩之寶將更加關注利潤率。瑞銀也表示，樹脂成本每上漲10%，預計每股盈餘將增加約0.08美元；而進出境運費每上漲10%，預計每股盈餘將增加約0.09美元。 瑞銀補充道，即使面臨輕微的供應鏈中斷，預計孩之寶仍將維持其2026年的營收預期。 瑞銀維持買進評級，目標價為110美元。
Price: $95.34, Change: $-1.81, Percent Change: -1.86%
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.